pcat®3-enhancer vector Search Results


pcat®3-enhancer vector  (Promega)
90
Promega pcat®3-enhancer vector
Comparison of the dual reporter system with the conventional CAT reporter system. The same promoter regions used in the dual reporter vector system were re-cloned into the CAT reporter system, <t>pCAT®3-Enhancer</t> vector (A). Vectors harboring different lengths of the promoter region were cotransfected with pSV-β-Galactosidase vector. The transcriptional activities of each region were determined via Chloramphenicol acetyl transferase activity assays (B, C) after compensation with beta-galactosidase. The pCAT3 control vector without the promoter sequence (pCAT®3-Basic) and the one harboring the SV40 promoter (pCAT®3-Control) were used as negative and positive controls, respectively.
Pcat®3 Enhancer Vector, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/pcat+basic+plasmid/pmc02816957-69-13-19
Average 90 stars, based on 1 article reviews
pcat®3-enhancer vector - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
simultaneous pet spect imaging  (MILabs)
94
MILabs simultaneous pet spect imaging
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Simultaneous Pet Spect Imaging, supplied by MILabs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/PET%2FSPECT/pmc06599172-5-0-5
Average 94 stars, based on 1 article reviews
simultaneous pet spect imaging - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
milabs vector6 spect ct system  (MILabs)
97
MILabs milabs vector6 spect ct system
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Milabs Vector6 Spect Ct System, supplied by MILabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/Single+photon+Emission+Computed+Tomography/10__1016_slash_j__eanmi__2026__100145-76-9-9
Average 97 stars, based on 1 article reviews
milabs vector6 spect ct system - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier
vectorv r novaredtm substrate kit  (Vector Laboratories)
96
Vector Laboratories vectorv r novaredtm substrate kit
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Vectorv R Novaredtm Substrate Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/VECTOR+NovaRED+Peroxidase+(HRP)+Substrate+Kit/10__1042_slash_bsr20171366-66-15-20
Average 96 stars, based on 1 article reviews
vectorv r novaredtm substrate kit - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
cy3 labeled peanut agglutinin (pna)  (Vector Laboratories)
94
Vector Laboratories cy3 labeled peanut agglutinin (pna)
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Cy3 Labeled Peanut Agglutinin (Pna), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/Cy3+labeled+Peanut+Agglutinin+(PNA)/custom%40cl-1073%4010614682
Average 94 stars, based on 1 article reviews
cy3 labeled peanut agglutinin (pna) - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
csu-w1  (Yokogawa Electric)
99
Yokogawa Electric csu-w1
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Csu W1, supplied by Yokogawa Electric, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/CSU-W1/custom%40csu-w1%4010%2E2307%2F1911105
Average 99 stars, based on 1 article reviews
csu-w1 - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
vectorr vip substrate kit for peroxidase  (Vector Laboratories)
95
Vector Laboratories vectorr vip substrate kit for peroxidase
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Vectorr Vip Substrate Kit For Peroxidase, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/VECTOR+VIP+Peroxidase+(HRP)+Substrate+Kit/pmc02740418-255-11-17
Average 95 stars, based on 1 article reviews
vectorr vip substrate kit for peroxidase - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
vectastain elite abc hrp kit (peroxidase, standard)  (Vector Laboratories)
99
Vector Laboratories vectastain elite abc hrp kit (peroxidase, standard)
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Vectastain Elite Abc Hrp Kit (Peroxidase, Standard), supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/VECTASTAIN+Elite+ABC+HRP+Kit+(Peroxidase%2C+Standard)/custom%40pk-6100%4037607030
Average 99 stars, based on 1 article reviews
vectastain elite abc hrp kit (peroxidase, standard) - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier
aav8-cag-gfp  (Vector Biolabs)
95
Vector Biolabs aav8-cag-gfp
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Aav8 Cag Gfp, supplied by Vector Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/AAV8-CAG-GFP/custom%407075%4037534168
Average 95 stars, based on 1 article reviews
aav8-cag-gfp - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
vecter abc kit  (Vector Laboratories)
96
Vector Laboratories vecter abc kit
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Vecter Abc Kit, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/Avidin%2FBiotin+Blocking+Kit/pm17277753-45-9-12
Average 96 stars, based on 1 article reviews
vecter abc kit - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
vectared detection reagent  (Vector Laboratories)
96
Vector Laboratories vectared detection reagent
<t>(A)</t> <t>PET/SPECT</t> images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).
Vectared Detection Reagent, supplied by Vector Laboratories, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pcat%C2%AE3-enhancer+vector/VECTOR+Red+Alkaline+Phosphatase+(Red+AP)+Substrate+Kit/pmc03385560-154-7-10
Average 96 stars, based on 1 article reviews
vectared detection reagent - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Comparison of the dual reporter system with the conventional CAT reporter system. The same promoter regions used in the dual reporter vector system were re-cloned into the CAT reporter system, pCAT®3-Enhancer vector (A). Vectors harboring different lengths of the promoter region were cotransfected with pSV-β-Galactosidase vector. The transcriptional activities of each region were determined via Chloramphenicol acetyl transferase activity assays (B, C) after compensation with beta-galactosidase. The pCAT3 control vector without the promoter sequence (pCAT®3-Basic) and the one harboring the SV40 promoter (pCAT®3-Control) were used as negative and positive controls, respectively.

Journal: Immune Network

Article Title: A New Reporter Vector System Based on Flow-Cytometry to Detect Promoter Activity

doi: 10.4110/in.2009.9.6.243

Figure Lengend Snippet: Comparison of the dual reporter system with the conventional CAT reporter system. The same promoter regions used in the dual reporter vector system were re-cloned into the CAT reporter system, pCAT®3-Enhancer vector (A). Vectors harboring different lengths of the promoter region were cotransfected with pSV-β-Galactosidase vector. The transcriptional activities of each region were determined via Chloramphenicol acetyl transferase activity assays (B, C) after compensation with beta-galactosidase. The pCAT3 control vector without the promoter sequence (pCAT®3-Basic) and the one harboring the SV40 promoter (pCAT®3-Control) were used as negative and positive controls, respectively.

Article Snippet: Several promoter regions used in the dual reporter vector were re-cloned into the CAT expression vector system pCAT®3-Enhancer vector (Promega, Madison, WI), in order to ascertain whether these regions evidenced similar transcription activity in the CAT assay system ( ).

Techniques: Plasmid Preparation, Clone Assay, Chloramphenicol Acetyltransferase Assay, Activity Assay, Sequencing

(A) PET/SPECT images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-468 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (C) Tumour-to-blood ratios and (D) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection

(A) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance; *P < 0.05).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (ns: no statistical significance; *P < 0.05).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay

(A) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (*P < 0.05; ****P < 0.0001).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing MDA-MB-231/H2N tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (*P < 0.05; ****P < 0.0001).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay

(A) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (***P < 0.001; ****P < 0.0001).

Journal: Nuclear Medicine and Biology

Article Title: Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours ☆ ☆☆

doi: 10.1016/j.nucmedbio.2019.01.010

Figure Lengend Snippet: (A) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG. (B) PET/SPECT images of mice bearing SKBR3 tumours at 3 days post injection of [ 89 Zr]Zr-trastuzumab, [ 111 In]In-IgG, and a blocking dose (0.5 mg) of unlabelled trastuzumab. (C) Biodistribution data showing uptake (%ID/g) of each radiolabelled agent in tumours and selected organs. (D) Tumour-to-blood ratios and (E) tumour-to-muscle ratios for each radiolabelled agent. (***P < 0.001; ****P < 0.0001).

Article Snippet: Simultaneous PET/SPECT imaging using a MILabs Vector4 small animal scanner revealed stark differences in the intratumoural distribution of [ 89 Zr]Zr-trastuzumab and [ 111 In]In-IgG, highlighting regions of HER2-mediated uptake and non-specific uptake, respectively.

Techniques: Single Photon Emission Computed Tomography, Injection, Blocking Assay